Tacrolimus
Product Description
Ceres F&D Inc.
-
Country/Region:Korea, Republic Of
-
On CPHI since:2021
Company types
Categories
Ceres F&D Inc.
-
Country/Region:Korea, Republic Of
-
On CPHI since:2021
Company types
More Products from Ceres F&D Inc. (1)
-
Product Tergase®
1. Component: - Recombinant human hyaluronidase
2. Indication: - Tergase® is a stand-alone pharmaceutical version of Recombinant human hyaluronidase which is currently under clinical trial aiming marketing approval in the 3Q of 2022 from MFDS, South Korea. Through the inh...
